X-linked inhibitor of apoptosis protein deficiency complicated with Crohn's disease-like enterocolitis and Takayasu arteritis: A case report.


Journal

Clinical immunology (Orlando, Fla.)
ISSN: 1521-7035
Titre abrégé: Clin Immunol
Pays: United States
ID NLM: 100883537

Informations de publication

Date de publication:
08 2020
Historique:
received: 07 04 2020
revised: 04 06 2020
accepted: 07 06 2020
pubmed: 17 6 2020
medline: 2 2 2021
entrez: 17 6 2020
Statut: ppublish

Résumé

X-linked inhibitor of apoptosis protein (XIAP) deficiency results in monogenic inflammatory bowel disease. To date, no vasculitis associated with XIAP deficiency has been reported. A 10-year-old boy was diagnosed with Crohn's disease and he responded poorly to conventional treatment for Crohn's disease. He was dependent on corticosteroids and parenteral nutrition. To manage severe colitis, he underwent ileostomy followed by ileocolectomy for an ileo-sigmoid fistula. At the age of 15 years, he developed IgA vasculitis and at the age of 17 years, he developed refractory Takayasu arteritis (TAK), which was resistant to corticosteroid and immunosuppressive therapy. Whole-exome sequencing revealed a novel mutation of the splice acceptor site in XIAP (c.1057-1G > A) at the age of 19 years. Allogeneic hematopoietic stem cell transplantation was successful with subsequent withdrawal of intensive immunosuppressive therapy and clinical remission of both enterocolitis and TAK. This case suggests that patients with XIAP deficiency could develop intractable inflammatory disease involving the intestinal tract and blood vessels.

Identifiants

pubmed: 32540394
pii: S1521-6616(20)30226-6
doi: 10.1016/j.clim.2020.108495
pii:
doi:

Substances chimiques

X-Linked Inhibitor of Apoptosis Protein 0
XIAP protein, human 0

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

108495

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Ichiro Takeuchi (I)

Center for Pediatric Inflammatory Bowel Disease, Division of Gastroenterology, National Center for Child Health and Development, Tokyo, Japan. Electronic address: takeuchi-i@ncchd.go.jp.

Toshinao Kawai (T)

Division of Immunology, National Center for Child Health and Development, Tokyo, Japan.

Meika Nambu (M)

Division of Immunology, National Center for Child Health and Development, Tokyo, Japan.

Ohsuke Migita (O)

Department of Maternal-Fetal Biology, National Research Institute for Child Health and Development, Tokyo, Japan.

Satoshi Yoshimura (S)

Department of Transplantation and Cell Therapy, Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.

Kenichi Nishimura (K)

Department of Pediatrics, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.

Takako Yoshioka (T)

Department of Pathology, Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.

Masao Ogura (M)

Division of Nephrology and Rheumatology, National Center for Child Health and Development, Tokyo, Japan.

Reiko Kyodo (R)

Center for Pediatric Inflammatory Bowel Disease, Division of Gastroenterology, National Center for Child Health and Development, Tokyo, Japan.

Hirotaka Shimizu (H)

Center for Pediatric Inflammatory Bowel Disease, Division of Gastroenterology, National Center for Child Health and Development, Tokyo, Japan.

Shuichi Ito (S)

Department of Pediatrics, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.

Motohiro Kato (M)

Department of Transplantation and Cell Therapy, Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.

Masafumi Onodera (M)

Division of Immunology, National Center for Child Health and Development, Tokyo, Japan.

Kenichiro Hata (K)

Department of Maternal-Fetal Biology, National Research Institute for Child Health and Development, Tokyo, Japan.

Yoichi Matsubara (Y)

National Research Institute for Child Health and Development, Tokyo, Japan.

Katsuhiro Arai (K)

Center for Pediatric Inflammatory Bowel Disease, Division of Gastroenterology, National Center for Child Health and Development, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH